Results 171 to 180 of about 53,966 (229)

Sorafenib plus selective internal radiotherapy with ⁹⁰Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial. [PDF]

Br J Cancer
Berthod G, Cisarovsky C, Petrova T, Decosterd LA, Choong E, Celestini D, Cuendet MA, Boughdad S, Prior JO, Meuwly JY, Figg WD, Michielin O, Leyvraz S.   +12 more
europepmc   +1 more source

Alpha‐Fetoprotein Stimulates Cleavage of Membranal MICA/B on Liver Cancer Cell Lead to Escape Immune Surveillance of Natural Killer Cells

Journal of Cellular and Molecular Medicine, Volume 30, Issue 5, March 2026.
ABSTRACT Hepatocellular carcinoma (HCC) could escape immune surveillance. Alpha‐fetoprotein (AFP) serves as a significant biomarker for HCC; however, its influence on HCC immune surveillance remains elusive. RNA‐Seq data of HCC were obtained from TCGA and GEO databases for the expression of AFP, MICA/B, and related genes.
Xiaowei Li, Siren Feng, Xueqin Wu, Yinglian Pan, Yuli Zhou, Kun Liu, Bo Lin, Wei Li, Mengsen Li, Mingyue Zhu   +9 more
wiley   +1 more source

A network meta-analysis of first-line treatment options for patients with Child-Pugh class B functional hepatocellular carcinoma: comparison of efficacy and safety. [PDF]

Front Pharmacol
Zhang YX, Wu JY, Wu JY, Zeng ZX, Pan RJ, Ou XY, Li YN, Yan ML.   +7 more
europepmc   +1 more source

Comparing of Efficacy and Safety Between Sintilimab Plus IBI305 and PD‐1 Inhibitor Plus TKIs in Combination of TACE for uHCC

Liver International, Volume 46, Issue 3, March 2026.
ABSTRACT Background Systemic therapy combined with transcatheter arterial chemoembolization (TACE) is the main treatment strategy for patients with unresectable hepatocellular carcinoma (uHCC). Nevertheless, there are currently few direct comparative studies between different combined treatment regimens.
Houxiang Ya, Kai Wang, Huixia Qin, Yi Zhou, Hesheng Lin, Chengyuan Liu, Kaiwen Jiang, Jing Gu, Shuqun Li   +8 more
wiley   +1 more source

Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis. [PDF]

Ann Med
Ying T, E S, Ying H.
europepmc   +1 more source

Harnessing blue light photobiomodulation for cancer therapy: Evidence from a systematic review

Photochemistry and Photobiology, Volume 102, Issue 2, Page 370-399, March/April 2026.
Conventional treatments for various types of cancer are often associated with tumor recurrence and aggressiveness. Photobiomodulation with blue light (BL; 450–470 nm) emerges as a promising alternative with antitumor effects. This systematic review, with 37 in vitro and in vivo studies from 2002 to 2024, revealed that BL reduces cell viability ...
Bárbara Evelyn Santos de Lima, Rebeca Barros Nascimento, Ana Paula Mariano Santos Ginez, Maria Stella Moreira, Rebeca Boltes Cecatto, Rodrigo Labat Marcos, Maria Fernanda Setúbal Destro Rodrigues   +6 more
wiley   +1 more source

Effect of the antifungal drug ciclopirox on the inhibition of HMGA2-mediated oncogenic capacity in ACHN renal cell carcinoma. [PDF]

Front Pharmacol
Liu X, Su J, Song L, Fu Q, Li X, Li J, Liu Y, Liao J.   +7 more
europepmc   +1 more source

Impact of anticancer drugs on human Tenon's fibroblast proliferation: implications for glaucoma surgery. [PDF]

BMJ Open Ophthalmol
Villa V, Marengo B, Cutolo CA, Passalacqua M, Vernazza S, Montalto G, Pronzato MA, Iester M, Ricciarelli R.   +8 more
europepmc   +1 more source

Short and Long Non-Coding RNAs in Renal Cell Carcinoma. [PDF]

Noncoding RNA
Cecati M, Pozzi V, Schiavoni V, Barrasso G, Pompei V, Marzioni D, Bonci N, Fumarola S, Ballini A, Sartini D, Campagna R.   +10 more
europepmc   +1 more source